Publications by authors named "Maryann Foote"

Claim this Profile
B
Backing up your statements: how to perform literature searches to prove your points.
MaryAnn Foote

Chest· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proof of the pudding: how to report results and write a good discussion.
MaryAnn Foote

Chest· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abstracts for professional meetings: small but mighty.
MaryAnn Foote

Chest· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical review and appraisal of published clinical literature: useful skill in biotechnology product development.
Maryann Foote

Biotechnol Annu Rev· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using nanotechnology to improve the characteristics of antineoplastic drugs: improved characteristics of nab-paclitaxel compared with solvent-based paclitaxel.
MaryAnn Foote

Biotechnol Annu Rev· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Materials and methods: a recipe for success.
Maryann Foote

Chest· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial registries and clinical trial result posting: new paradigm for medical writers.
MaryAnn Foote

Biotechnol Annu Rev· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical writing departments in biopharma companies: how to establish a department.
MaryAnn Foote, Karen Soskin

Biotechnol Annu Rev· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why references: giving credit and growing the field.
Maryann Foote

Chest· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to make a good first impression: a proper introduction.
Maryann Foote

Chest· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge.
Ralph Smalling, MaryAnn Foote, Graham Molineux, Steven J Swanson, Steve Elliott

Biotechnol Annu Rev· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using the biologic license application or new drug application as a basis for the common technical document.
MaryAnn Foote

Biotechnol Annu Rev· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines and policies for medical writers in the biotech industry: an update on the controversy.
MaryAnn Foote

Biotechnol Annu Rev· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
Carol Anne Sawka, Frances A Shepherd, Edmee Franssen, Joseph Brandwein, Dale A Dotten, MaryAnn Foote

Biotechnol Annu Rev· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Some concrete ideas about manuscript abstracts.
Maryann Foote

Chest· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments on European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications.
Maryann Foote, Cindy W Hamilton, Marianne Mallia-Hughes

Curr Med Res Opin· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of high-quality marketing applications: strategies for biotechnology companies working with contract research organizations.
Sandra J Hecker, Christopher Preston, MaryAnn Foote

Biotechnol Annu Rev· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of current authorship guidelines and the controversy regarding publication of clinical trial data.
MaryAnn Foote

Biotechnol Annu Rev· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of supportive-care agents for patients with cancer.
Theresa K Neumann, MaryAnn Foote

Biotechnol Annu Rev· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia.
Johan Vansteenkiste, Gregory Rossi, MaryAnn Foote

Expert Opin Biol Ther· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic and cytokine treatment of commonly encountered anemias.
MaryAnn Foote, Alan Colowick, David A Goodkin

Cytokines Cell Mol Ther· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis